Figure 6
Figure 6. p210 leukemia is sensitive to GVL mediated by donor-derived TNF and LTα3. (A) Leukemic relapse by Kaplan-Meier analysis in lethally irradiated (1100 cGy) B6C3F1 recipients transplanted with 5 × 106 BM and 0.5 × 106 T cells from B6.WT, B6.Lta−/−, B6.Tnf−/− or B6.Tnf/Lta−/− mice or 5 × 106 B6.WT TCD BM, in conjunction with 1 × 106 p210 tumor cells (H-2Dk, luciferase+). P = .024 Lta−/− vs Tnf/Lta−/−. P = .048, Tnf−/− vs Tnf/Lta−/−. P < .0001 Tnf/Lta−/− vs WT. P = .048 Tnf−/− vs WT, T cell–replete groups. Data are combined from 2 replicate experiments, n = 16 in BM + T groups and n = 10 in TCD control. (B) Representative bioluminescent imaging, taken at day 19 after transplantation.

p210 leukemia is sensitive to GVL mediated by donor-derived TNF and LTα3. (A) Leukemic relapse by Kaplan-Meier analysis in lethally irradiated (1100 cGy) B6C3F1 recipients transplanted with 5 × 106 BM and 0.5 × 106 T cells from B6.WT, B6.Lta−/−, B6.Tnf−/− or B6.Tnf/Lta−/− mice or 5 × 106 B6.WT TCD BM, in conjunction with 1 × 106 p210 tumor cells (H-2Dk, luciferase+). P = .024 Lta−/− vs Tnf/Lta−/−. P = .048, Tnf−/− vs Tnf/Lta−/−. P < .0001 Tnf/Lta−/− vs WT. P = .048 Tnf−/− vs WT, T cell–replete groups. Data are combined from 2 replicate experiments, n = 16 in BM + T groups and n = 10 in TCD control. (B) Representative bioluminescent imaging, taken at day 19 after transplantation.

Close Modal

or Create an Account

Close Modal
Close Modal